about
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate ...
Read More
0.29
0.00
(0.00%)
356.7K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Split
Immutep Limited - ADR has split the face value of its shares from $1 to $20 on 28 Sep 2026.
See details
Not Eligible
Expensive Valuation
Technically Bearish
Immutep Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..